Search

everythinglearnresearchcommunity

for

Search:↓

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Adrenal disorders can cause lasting brain and behavior issues in children.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.